Jacobs Levy Equity Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-6,423
| Closed | -$239K | – | 1015 |
|
2022
Q2 | $239K | Hold |
6,423
| – | – | ﹤0.01% | 947 |
|
2022
Q1 | $284K | Sell |
6,423
-2,056
| -24% | -$90.9K | ﹤0.01% | 929 |
|
2021
Q4 | $360K | Sell |
8,479
-73,928
| -90% | -$3.14M | ﹤0.01% | 878 |
|
2021
Q3 | $3.58M | Buy |
+82,407
| New | +$3.58M | 0.02% | 500 |
|
2018
Q1 | – | Sell |
-18,810
| Closed | -$466K | – | 1004 |
|
2017
Q4 | $466K | Buy |
+18,810
| New | +$466K | 0.01% | 767 |
|
2016
Q2 | – | Sell |
-107,030
| Closed | -$2.01M | – | 1162 |
|
2016
Q1 | $2.01M | Sell |
107,030
-692,870
| -87% | -$13M | 0.04% | 408 |
|
2015
Q4 | $14.8M | Buy |
799,900
+84,200
| +12% | +$1.55M | 0.29% | 112 |
|
2015
Q3 | $11.7M | Sell |
715,700
-195,230
| -21% | -$3.2M | 0.24% | 128 |
|
2015
Q2 | $16.1M | Sell |
910,930
-87,600
| -9% | -$1.55M | 0.31% | 112 |
|
2015
Q1 | $17.7M | Sell |
998,530
-823,958
| -45% | -$14.6M | 0.3% | 114 |
|
2014
Q4 | $24.1M | Buy |
1,822,488
+458,560
| +34% | +$6.08M | 0.41% | 71 |
|
2014
Q3 | $16.1M | Sell |
1,363,928
-4,200
| -0.3% | -$49.6K | 0.27% | 123 |
|
2014
Q2 | $17.5M | Buy |
+1,368,128
| New | +$17.5M | 0.29% | 112 |
|
2014
Q1 | – | Sell |
-12,230
| Closed | -$147K | – | 897 |
|
2013
Q4 | $147K | Buy |
+12,230
| New | +$147K | ﹤0.01% | 887 |
|
2013
Q3 | – | Sell |
-1,129,900
| Closed | -$10.5M | – | 931 |
|
2013
Q2 | $10.5M | Buy |
+1,129,900
| New | +$10.5M | 0.19% | 161 |
|